MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 148 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.16 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $239,365 | +14.4% | 7,001 | -15.9% | 0.00% | – |
| Q1 2024 | $209,174 | -13.8% | 8,327 | +1.3% | 0.00% | – |
| Q4 2023 | $242,743 | -7.6% | 8,223 | -1.1% | 0.00% | – |
| Q3 2023 | $262,628 | +17.7% | 8,311 | -3.7% | 0.00% | – |
| Q2 2023 | $223,206 | -67.2% | 8,628 | -75.3% | 0.00% | -100.0% |
| Q2 2022 | $681,000 | – | 34,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,621,118 | $41,938,323 | 46.52% |
| Frazier Life Sciences Management, L.P. | 4,360,107 | $112,795,968 | 6.74% |
| Prosight Management, LP | 1,350,000 | $34,924,500 | 5.23% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $29,416,958 | 4.33% |
| NEA Management Company, LLC | 2,186,243 | $56,558,106 | 4.32% |
| Highlander Partners, L.P. | 122,980 | $3,181,493 | 3.58% |
| Novo Holdings A/S | 1,684,193 | $43,570,073 | 3.37% |
| Nicholas Investment Partners, LP | 915,119 | $23,674,129 | 1.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,264,922 | $32,723,532 | 1.55% |
| Eventide Asset Management | 3,459,201 | $89,489,530 | 1.51% |